Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Computing
Conference & Expo
November 2-4, 2009 NYC
Register Today and SAVE !..

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
In many cases, the end of the year gives you time to step back and take stock of the last 12 months. This is when many of us take a hard look at what worked and what did not, complete performance reviews, and formulate plans for the coming year. For me, it is all of those things plus a time when I u...
SYS-CON.TV
Plunkett's Biotech & Genetics Industry Almanac 2013: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies

NEW YORK, Feb. 11, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Plunkett's Biotech & Genetics Industry Almanac 2013: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies

http://www.reportlinker.com/p01027637/-Plunketts-Biotech--Genetics-Indus...

PLUNKETT'S BIOTECH & GENETICS INDUSTRY ALMANAC 2013

Key Features:

-Industry trends analysis, market data and competitive intelligence

-Market forecasts and Industry Statistics

-Industry Associations and Professional Societies List

-In-Depth Profiles of hundreds of leading companies

-Industry Glossary

-Buyer may register for access to search and export data at Plunkett Research Online

Pages: 537Statistical Tables Provided: 18Companies Profiled: 353Geographic Focus: Global

A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms. You will gain vital insights that can help you shape your own strategy for business development, product development and investments.

-How is the industry evolving?

-How is the industry being shaped by new technologies?

-How is demand growing in emerging markets and mature economies?

-What is the size of the market now and in the future?

-What are the financial results of the leading companies?

-What are the names and titles of top executives?

-What are the top companies and what are their revenues?

Contents, Statistics, Forecasts and Analysis Include:

Major Trends Affecting the Biotech & Genetics Industry

1) The State of the Biotechnology Industry Today

2) A Short History of Biotechnology

3) Ethanol Production Soars, But U.S. Federal Subsidy in Question

4) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms

5) From India to Singapore to China, Nations Compete Fiercely in Biotech Development

6) Clinical Trials and Medical Records Processing Conducted Abroad Spark Concerns

7) Gene Therapies and Patients' Genetic Profiles Promise a Personalized Approach to Medicine

8) Breakthrough Drugs for Cancer Treatment—Many More Will Follow

9) Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues

10) Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age

11) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce

12) Breakthrough New Drug Delivery Systems Evolve

13) Stem Cells—Multiple Sources Stem from New Technologies

14) Government Support for Stem Cell Research Evolves

15) Stem Cells—Therapeutic Cloning Techniques Advance

16) Stem Cells—A New Era of Regenerative Medicine Takes Shape

17) Nanotechnology Converges with Biotech

18) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/Selective Breeding Offers a Compromise

19) Focus on Vaccines

20) Technology Discussion—Genomics

21) Technology Discussion—Proteomics

22) Technology Discussion—Microarrays

23) Technology Discussion—DNA Chips

24) Technology Discussion—SNPs ("Snips")

25) Technology Discussion—Combinatorial Chemistry

26) Technology Discussion—Synthetic Biology

27) Technology Discussion—Recombinant DNA

28) Technology Discussion—Polymerase Chain Reaction (PCR)

Biotech & Genetics Industry Statistics

1) Biotech Industry Overview

2) The U.S. Drug Discovery & Approval Process

3) U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2011

4) U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals:1993-2011

5) Employment in Life & Physical Science Occupations, U.S.: May 2011

6) Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2011-2013

7) U.S. Exports & Imports of Pharmaceutical Products: 2007-1st Quarter 2012

8) U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2006-2021

9) U.S. Prescription Drug Expenditures: 1970-2021

10) Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2011

11) Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2011-2013

12) Global Area of Biotech Crops by Country: 2011

13) Biologics & Biotechnology R&D, PhRMA Member Companies: 2010

14) Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1975-2011

15) Sales By Geographic Area, PhRMA Member Companies: 2010

16) Domestic U.S. Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 2010

17) Domestic Biopharmaceutical R&D Scientific, Professional & Technical Personnel by Function, PhRMA Member Companies: 2010

18) Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1975-2011

Table of Contents

PLUNKETT'S BIOTECH & GENETICSINDUSTRY ALMANAC 2013CONTENTSA Short Biotech & Genetics Industry Glossary xIntroduction 1How to Use This Book 3Chapter 1: Major Trends Affecting the Biotech & Genetics Industry 71) The State of the Biotechnology Industry Today 82) A Short History of Biotechnology 133) Ethanol Production Soars, But U.S. Federal Subsidy in Question 144) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms 175) From India to Singapore to China, Nations Compete Fiercely in Biotech Development 186) Clinical Trials and Medical Records Processing Conducted Abroad Spark Concerns 207) Gene Therapies and Patients' Genetic Profiles Promise a Personalized Approach toMedicine 218) Breakthrough Drugs for Cancer Treatment—Many More Will Follow 249) Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues 2510) Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age 2711) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce 2812) Breakthrough New Drug Delivery Systems Evolve 3013) Stem Cells—Multiple Sources Stem from New Technologies 3014) Government Support for Stem Cell Research Evolves 3215) Stem Cells—Therapeutic Cloning Techniques Advance 3316) Stem Cells—A New Era of Regenerative Medicine Takes Shape 3517) Nanotechnology Converges with Biotech 3718) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/SelectiveBreeding Offers a Compromise 3819) Focus on Vaccines 4120) Technology Discussion—Genomics 4221) Technology Discussion—Proteomics 4222) Technology Discussion—Microarrays 4323) Technology Discussion—DNA Chips 4324) Technology Discussion—SNPs ("Snips") 4425) Technology Discussion—Combinatorial Chemistry 4426) Technology Discussion—Synthetic Biology 4427) Technology Discussion—Recombinant DNA 4528) Technology Discussion—Polymerase Chain Reaction (PCR) 45Chapter 2: Biotech & Genetics Industry Statistics 46Biotech Industry Overview 47The U.S. Drug Discovery & Approval Process 48U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2011 49U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME)Approvals:1993-2011 50Employment in Life & Physical Science Occupations, U.S.: May 2011 51Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.:Fiscal Years 2011-2013 52U.S. Exports & Imports of Pharmaceutical Products: 2007-1st Quarter 2012 53U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution:2006-2021 54U.S. Prescription Drug Expenditures: 1970-2021 56Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2011 58Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years2011-2013 59Global Area of Biotech Crops by Country: 2011 60Biologics & Biotechnology R&D, PhRMA Member Companies: 2010 61Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1975-2011 62Sales By Geographic Area, PhRMA Member Companies: 2010 63Domestic U.S. Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 2010 64Domestic Biopharmaceutical R&D Scientific, Professional & Technical Personnel by Function,PhRMA Member Companies: 2010 65Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1975-2011 66Chapter 3: Important Biotech & Genetics Industry Contacts 67(Addresses, Phone Numbers and Internet Sites)Chapter 4: THE BIOTECH 350:Who They Are and How They Were Chosen 106Industry List, With Codes 107Index of Companies Within Industry Groups 108Alphabetical Index 116Index of U.S. Headquarters Location by State 119Index of Non-U.S. Headquarters Location by Country 122Index by Regions of the U.S. Where the Firms Have Locations 124Index by Firms with International Operations 130Individual Profiles on Each of THE BIOTECH 350 132Additional IndexesIndex of Hot Spots for Advancement for Women/Minorities 487Index by Subsidiaries, Brand Names and Selected Affiliations 489

Companies Mentioned

23AndMe Inc3SBio Inc4SC AGAastrom Biosciences IncAbaxis IncAbbott LaboratoriesAccelrys IncAccess Pharmaceuticals IncActelion LtdAdamis Pharmaceuticals CorporationAdolor CorpAdvanced Cell Technology IncAdvanced Life Sciences Holdings IncAdvanSource Biomaterials CorporationAeolus Pharmaceuticals IncAEterna Zentaris IncAffymetrix IncAgenus IncAgilent Technologies IncAkorn IncAlbany Molecular Research IncAlcon IncAldagen IncAlexion Pharmaceuticals IncAlimera Sciences IncAlkermes plcAllergan IncAlliance Pharmaceutical CorpAllos Therapeutics IncAlseres Pharmaceuticals IncAmarin Corporation plcAmgen IncAmpliPhi Biosciences CorporationAmylin Pharmaceuticals IncAmyris Biotechnologies IncAnacor Pharmaceuticals IncAngiotech Pharmaceuticals IncAnika Therapeutics IncAPP Pharmaceuticals IncApplied Molecular Evolution IncApricus Biosciences IncAptalis PharmaAradigm CorporationArcadia Biosciences IncArena Pharmaceuticals IncAriad Pharmaceuticals IncArQule IncArray BioPharma IncArryx IncAstellas Pharma IncAstex Pharmaceuticals IncAstraZeneca CanadaAstraZeneca plcAvanir PharmaceuticalsAVAX Technologies IncAVIVA Biosciences CorpBASF SEBausch & Lomb IncBaxter International IncBayer AGBayer CorpBayer Healthcare PharmaceuticalsBIND Biosciences IncBio Rad Laboratories IncBioanalytical Systems IncBiocancell Therapeutics IncBiocompatibles International LtdBioCryst Pharmaceuticals IncBiogen IDEC IncBioheart IncBioMarin Pharmaceutical IncBiomet IncBioNano GenomicsBioReliance CorpBiosite IncBioTime IncBrachyTherapy Services IncBristol-Myers Squibb CoBroadSoft IncBurrill & CompanyCaliper Life Sciences IncCambrex CorpCangene bioPharma IncCangene CorpCaraco Pharmaceutical Laboratories LtdCardiome Pharma CorpCardium Therapeutics IncCegedim SACelera CorporationCelgene CorpCell Therapeutics IncCellartis ABCelldex Therapeutics IncCellular Dynamics InternationalCEL-SCI CorporationCelsis International plcCephalon IncCepheidCerus CorporationCharles River Laboratories International IncClaros Diagnostics IncCML Healthcare IncColumbia Laboratories IncComplete Genomics IncCompugen LtdCortex Pharmaceuticals IncCovance IncCovidien plcCrucell NVCSL LimitedCubist Pharmaceuticals IncCumberland Pharmaceuticals IncCuris IncCytRx CorporationDaiichi Sankyo Co LtdDainippon Sumitomo Pharma Co LtddeCODE genetics LtdDendreon CorporationDepomed IncdiaDexus IncDiscovery Laboratories IncDivi's Laboratories LimitedD-Medical Industries LtdDow AgroSciences LLCDr Reddy's Laboratories LimitedDSM Pharmaceutical Products IncDuPont (E I du Pont de Nemours & Co)DuPont Agriculture & NutritionDurect CorpDUSA Pharmaceuticals IncDyax CorpEisai Co LtdElan Corp plcEli Lilly & CompanyEmisphere Technologies IncEncorium Group IncEndo Health Solutions IncEntreMed IncEnzo Biochem IncEnzon Pharmaceuticals IncEpizymeeResearch Technology IncEUSA Pharma (USA) IncEvotec AGExelixis IncFlamel Technologies SAForest Laboratories IncGalderma Pharma SAGE HealthcareGenencor International IncGenentech IncGenerex Biotechnology CorporationGenMark Diagnostics IncGenocea BiosciencesGenomic Health IncGen-Probe IncGenta IncGenVec IncGenzyme BiosurgeryGenzyme CorpGenzyme OncologyGeron CorporationGilead Sciences IncGlaxoSmithKline plcGTC Biotherapeutics IncHarbor BioSciences IncHarvard Bioscience IncHemagen Diagnostics IncHemispherx Biopharma IncHeska CorpHi-Tech Pharmacal Co IncHospira IncHuman Genome Sciences IncHycor Biomedical IncI3 CanReg IncICON plcIdera Pharmaceuticals IncIDEXX Laboratories IncIllumina IncImClone Systems IncImmtech Pharmaceuticals IncImmuCell CorporationImmunoGen IncImmunomedics IncImmunomedics IncIMPAX Laboratories IncIMS Health IncIncyte CorpIndependence Resources plcInfinity Pharmaceuticals IncInSite Vision IncInsmed IncInstitut Straumann AGIntegra Lifesciences Holdings CorpIntelliPharmaCeutics International IncInterMune IncInternational Isotopes IncIon TorrentIronwood Pharmaceuticals IncIsis Pharmaceuticals IncJazz Pharmaceuticals plcJohnson & JohnsonJoule Unlimited TechnologiesJubilant Biosys LtdKeryx Biopharmaceuticals IncKV Pharmaceutical CoLa Jolla Pharmaceutical CompanyLannett Company IncLexicon Pharmaceuticals IncLife Technologies CorpLifeCell CorporationLifecore Biomedical IncLigand Pharmaceuticals IncLonza Group LtdLorus Therapeutics IncLuminex CorporationMarina Biotech IncMaxygen IncMedicines Co (The)Medicis Pharmaceutical CorpMedidata Solutions IncMedimmune IncMEDTOX Scientific IncMerck & Co IncMerck KGaAMerck Serono SAMeridian Bioscience IncMetabolix IncMetabolon IncMillennium Pharmaceuticals IncMillipore CorpMonsanto CoMylan IncMyriad Genetics IncMyriad RBMNabi BiopharmaceuticalsNanoBio CorporationNavidea Biopharmaceuticals IncNektar TherapeuticsNeogen CorporationNordion IncNovartis AGNovavax IncNoven Pharmaceuticals IncNovo-Nordisk ASNovozymesNPS Pharmaceuticals IncNycomedObagi Medical Products IncOncoGenex Pharmaceuticals IncOncothyreon IncOnyx Pharmaceuticals IncOraSure Technologies IncOrchid Cellmark IncOre Holdings IncOrganogenesis IncOSI Pharmaceuticals LLCOtsuka Holdings Co LtdOXiGENE IncPacific Biosciences of California IncPain Therapeutics IncPalatin Technologies IncPar Pharmaceutical Companies IncPAREXEL International CorpPDL BioPharmaPeregrine Pharmaceuticals IncPerrigo CoPfizer IncPharmaceutical Product Development IncPharmacyclics IncPharmaNet/i3Pharmathene IncPharmos CorpPharsight CorpPioneer Hi-Bred International IncPolydex Pharmaceuticals LtdPoniard Pharmaceuticals IncPozen IncPRA InternationalProgenics Pharmaceuticals IncPromega CorpProtein Polymer Technologies IncQIAGEN NVQLT IncQuest Diagnostics IncQuestcor Pharmaceuticals IncQuintiles Transnational CorpRanbaxy Laboratories LimitedRaptor Pharmaceutical CorpRegeneron Pharmaceuticals IncRepligen CorporationRepros Therapeutics IncRigel Pharmaceuticals IncRoche Holding LtdS&W Seed CoSalix PharmaceuticalsSangamo BioSciences IncSanofi SASarepta Therapeutics IncSavient Pharmaceuticals IncSciClone Pharmaceuticals IncScios IncSeattle GeneticsSequenom IncSeraCare Life Sciences IncShionogi IncShire Canada IncShire plcSiemens Healthcare DiagnosticsSIGA Technologies IncSigma-Aldrich CorpSimcere Pharmaceutical GroupSkyePharma plcSoligenix IncSpecialty Laboratories IncSpectral Diagnostics IncSpectrum Pharmaceuticals IncSpherix IncStemCells IncStiefel Laboratories IncSynageva BioPharma CorpSynbiotics CorpSyngenta AGSynovis Life Technologies IncSynthetic Genomics IncTakeda Pharmaceutical Company LtdTamir Biotechnology IncTaro Pharmaceutical IndustriesTechne CorpTelik IncTengion IncTeva Parenteral Medicines IncTeva Pharmaceutical Industries LtdTG Therapeutics IncTheragenics CorpThermo Fisher Scientific IncThermo ScientificTitan Pharmaceuticals IncTOLMAR IncToyobo Co LtdTrinity Biotech plcTripos InternationalTrius Therapeutics IncUCB SAUnigene Laboratories IncUnited Therapeutics CorpUnited-Guardian IncUrigen Pharmaceuticals IncValeant Pharmaceuticals InternationalVentria BioscienceVerenium CorporationVermillion IncVernalis plcVertex Pharmaceuticals IncViaCord IncVical IncVirbac CorpViroPharma IncVivus IncWarner Chilcott plcWatson Pharmaceuticals IncWhatman plcXDX IncXenoPort IncXOMA CorporationZIOPHARM Oncology IncZogenix IncZymoGenetics Inc

To order this report:: Plunkett's Biotech & Genetics Industry Almanac 2013: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

 

SOURCE Reportlinker

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

SOA World Latest Stories
As more applications and services move "to the cloud" (public or on-premise) cloud environments are increasingly adopting and building out traditional enterprise features. This in turn is enabling and encouraging cloud adoption from enterprise users. In many ways the definition is blur...
Internet of @ThingsExpo Silicon Valley announced on Friday its first 18 all-star speakers and sessions for its upcoming event, which will take place November 4-6, 2014, at the Santa Clara Convention Center in California. @ThingsExpo, the first and largest IoT event in the world, debute...
Until recently, many organizations required specialized departments to perform mapping and geospatial analysis, and they used Esri on-premise solutions for that work. In his session at 15th Cloud Expo, Dave Peters, author of the Esri Press book Building a GIS, System Architecture Des...
Back when we were doing DB2 at IBM, there was an important older product called IMS which brought significant revenue. With another database product coming (based on relational technology), IBM did not want any cannibalization of the existing revenue stream. Hence we coined the phrase ...
Nick O'Leary is an Emerging Technology Specialist at IBM where he gets to do interesting things with interesting technologies and also play with toys. With a background in pervasive messaging, he is a developer on the Eclipse Paho project and sits on the OASIS MQTT Technical Committee....
Bsquare is a global leader of embedded software solutions. We enable smart connected systems at the device level and beyond that millions use every day and provide actionable data solutions for the growing Internet of Things (IoT) market. We empower our world-class customers with our...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021


SYS-CON Featured Whitepapers
ADS BY GOOGLE